Caris Life Sciences, Inc.
CAI
$27.24
$1.134.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 24.33M | -71.79M | -102.58M | -67.73M | |
| Total Depreciation and Amortization | 4.87M | 6.41M | 7.05M | 10.53M | |
| Total Amortization of Deferred Charges | 2.46M | 7.76M | 1.95M | 1.83M | |
| Total Other Non-Cash Items | 16.68M | 66.35M | 48.93M | 2.74M | |
| Change in Net Operating Assets | 14.09M | -1.44M | 13.32M | -16.80M | |
| Cash from Operations | 62.43M | 7.29M | -31.34M | -69.43M | |
| Capital Expenditure | -7.10M | -1.39M | -2.69M | -1.83M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | 0.00 | |
| Cash from Investing | -7.10M | -1.39M | -2.69M | -1.83M | |
| Total Debt Issued | 0.00 | 27.87M | -- | 0.00 | |
| Total Debt Repaid | -23.00K | -22.00K | -22.00K | -26.00K | |
| Issuance of Common Stock | 1.15M | 529.65M | 1.43M | 655.00K | |
| Repurchase of Common Stock | -16.56M | -1.66M | -22.00K | -- | |
| Issuance of Preferred Stock | 0.00 | 121.24M | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -5.67M | 4.33M | -105.00K | -542.00K | |
| Cash from Financing | -21.10M | 681.40M | 1.29M | 87.00K | |
| Foreign Exchange rate Adjustments | 62.00K | 93.00K | 4.00K | -16.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 34.30M | 687.40M | -32.74M | -71.18M | |